Klow 80mg

$99.00

Multi-Peptide Research Blend | Cellular Signaling and Peptide Characterization

KLOW 80mg is a four-component peptide blend combining GHK-Cu, BPC-157, TB-500, and KPV in a single research preparation. The formulation is commonly described as containing 50mg of GHK-Cu and 10mg each of BPC-157, TB-500, and KPV, for a total labeled quantity of 80mg.

Each component has a distinct molecular structure and an individual research background. Together, they provide a multi-component preparation for laboratory analysis of peptide composition, molecular characteristics, and the scientific literature associated with each compound.

SKU KLOW80 Category

Description

PRODUCT OVERVIEW

Four Peptide Components in One Research Blend

KLOW combines four distinct research peptides:

· GHK-Cu (50mg): A copper-binding tripeptide studied in relation to extracellular matrix biology, copper coordination, and cellular signaling.

· BPC-157 (10mg): A synthetic pentadecapeptide investigated primarily in preclinical studies involving cellular and tissue-related biological processes.

· TB-500 (10mg): A commercial research peptide designation associated with thymosin beta-4-related research. The exact molecular identity should be confirmed against supplier documentation.

· KPV (10mg): A tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone, investigated in research involving cellular signaling and inflammatory pathways.

KLOW is a blend rather than a single molecular compound. The individual peptides have different structures and research profiles, and findings involving any one component do not establish the properties or effects of the complete formulation.

PRODUCT SPECIFICATIONS

Specification Details
Product Name KLOW 80mg
Compound Classification Four-component peptide blend
GHK-Cu 50mg
BPC-157 10mg
TB-500 10mg
KPV 10mg
Total Labeled Quantity 80mg
Price $99.00
Purity Refer to applicable product and lot documentation
Batch Identification Where provided
Supporting Documentation Applicable product or lot documentation

Confirm the stated composition and molecular identities against the supplier’s current specifications and applicable COA before publication.

SCIENTIFIC BACKGROUND

The four components in KLOW represent distinct areas of peptide research.

GHK-Cu has been studied for its copper-binding properties and interactions associated with extracellular matrix biology. BPC-157 has primarily been investigated in preclinical experimental models. Thymosin beta-4-related research has examined cellular migration and actin-associated processes, while KPV has been investigated in experimental studies involving cellular signaling and inflammatory pathways.

These findings relate to individual compounds and specific experimental conditions. Evidence for the separate ingredients does not establish the effectiveness, safety, or combined biological activity of KLOW itself. Research specifically evaluating this exact four-component formulation remains limited.

RESEARCH APPLICATIONS

KLOW 80mg may be examined in controlled laboratory settings for:

· Multi-Component Characterization: Evaluation of the reported identity and analytical properties of the blend’s individual components.

· Peptide-Metal Research: Investigation of copper coordination associated with GHK-Cu.

· Cellular Signaling Research: Examination of published findings associated with the individual peptide components.

· Comparative Peptide Analysis: Evaluation of differences between individual peptide materials and a combined preparation.

· Composition Assessment: Review of the stated component quantities and total labeled content.

· Analytical Documentation: Comparison of product specifications, reported purity, and available batch-specific findings.

These applications describe potential scientific research areas and do not establish clinical benefits or product-specific biological effects.

QUALITY & LABORATORY DOCUMENTATION

Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.

Researchers should review the available documentation for component identity, reported purity, analytical methods, laboratory information, and batch identification, where provided. For a multi-component preparation, documentation should identify the relevant components and correspond to the specific product lot being evaluated.

LOT & BATCH REFERENCE

Where a lot number or batch identifier is provided, retain it with the corresponding laboratory documentation. This supports traceability and helps researchers associate analytical findings with the relevant blend.

STORAGE & HANDLING

Store and handle KLOW 80mg according to the supplier-provided specifications and applicable laboratory procedures. Refer to the product-specific documentation for storage conditions, packaging requirements, and handling precautions.

RESEARCH USE STATEMENT

KLOW 80mg is offered strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.

IMPORTANT NOTICE

KLOW is a commercial blend designation, not the scientific name of a single peptide. The stated formulation should be verified against applicable product specifications and batch documentation before research use. No claim is made that this product is approved for human use or has established clinical benefits.

Reviews

There are no reviews yet.

Be the first to review “Klow 80mg”

Your email address will not be published. Required fields are marked *